Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin Bitterman currently holds 337,485 shares of GENOCEA BIOSCIENCES, INC. (GNCA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin Bitterman has been a net seller of GNCA stock. They have purchased $15.1M and sold $87.2M worth of shares.
Kevin Bitterman's most recent insider trade was on Dec 17, 2025, when they sold 213 shares at $91.47 per share.
Kevin Bitterman serves as Executive at GENOCEA BIOSCIENCES, INC. (GNCA). They have executed 99 insider transactions totaling $102.4M over their tenure at the company.
Kevin Bitterman holds the position of Executive at GENOCEA BIOSCIENCES, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Kevin Bitterman has shown a selling trading pattern, with $15.1M in total purchases and $87.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevin Bitterman was on Dec 16, 2025, when they sold $3.3M worth of IRON shares. This transaction involved 35,898 shares at $91.24 per share.
Kevin Bitterman currently owns 337,485 shares of GENOCEA BIOSCIENCES, INC. (GNCA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin Bitterman's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin Bitterman has 99 Form 4 filings on record as an insider at GENOCEA BIOSCIENCES, INC..
Set alerts for Kevin Bitterman and 40,000+ other insiders.